2017 CVM News: Dr. Brian VanderVen's paper pinpoints a new target for tuberculosis drugs

Thumbnail
View/Open
PERMANENT LINK(S)
https://hdl.handle.net/1813/52037
Collections
Metadata
Show full item record
Other Titles
New discovery holds potential as tuberculosis drug
Author
Office of Marketing and Communications. Media Relations
Abstract
The news item from the Cornell Chronicle is about: Dr. Brian VanderVen, assistant professor of microbiology and immunology, and colleagues at Cornell’s College of Veterinary Medicine, have discovered a key metabolic mechanism in Mycobacterium tuberculosis (Mtb) bacteria, which presents as a novel drug target for potentially treating tuberculosis. The finding is published in the journal eLife.
Date Issued
2017-06-27
Publisher
Cornell University, College of Veterinary Medicine
Subject
Cornell University. College of Veterinary Medicine -- Periodicals.; VanderVen, Brian; Roberts, Lauren Cahoon; Cornell Chronicle
Type
article

Statistics